Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Sesame Care

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · Sesame Care: October 2026

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade B+ · #3

Sesame Care

An established national telehealth marketplace carrying real brand-name GLP-1s — Wegovy (pen and pill), Zepbound, Ozempic, Mounjaro and the Foundayo pill — where most programs we rank carry none, plus provider-by-provider price transparency.

Visit Sesame Care

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 87/100 (grade A vs B+). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Sesame Care still earns its place — shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results86
97Price honesty80
96Prescriber access92
88Formulary choice95
95Cancellation fairness82
93Member support80

Price, coverage & features

MetricCoreAge RxSesame Care
Verdict Score94/10087/100
GradeAB+
Semaglutide$99/moFrom $149/mo (brand Wegovy pill)
Tirzepatide$149/moFrom $299/mo (brand Zepbound)
CoverageAll 50 statesNationwide marketplace
Brand-name accessCompounded onlyYes
Oral / sublingualNoYes

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Sesame Care

What we like

  • Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Foundayo
  • Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
  • You choose the provider and see the price up front — genuine marketplace transparency
  • Oral routes available (Wegovy pill, Foundayo)

The caveats

  • A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
  • Two-part cost: a $99/mo membership ($59/mo on the annual plan) is billed on top of the medication, so the true monthly total is harder to compare
  • Brand-name cash prices can run high without insurance — a maintenance month of Zepbound can pass $700 with the membership

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

Visit Sesame Care Read the full Sesame Care review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Sesame Care does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.